Company Overview of InCarda Therapeutics, Inc.
InCarda Therapeutics, Inc. develops transformative therapies that enable patients to use in the first moments of acute cardiovascular symptoms. The company develops an inhaled therapy intended to treat paroxysmal atrial fibrillation. InCarda Therapeutics, Inc. was formerly known as Pleiades Cardio-Therapeutics, Inc. The company was incorporated in 2009 and is based in San Francisco, California.
150 Post Street
San Francisco, CA 94108
Founded in 2009
Key Executives for InCarda Therapeutics, Inc.
InCarda Therapeutics, Inc. Key Developments
Similar Private Companies By Industry
|21st Century Animal Health||United States|
|3 Buds' Organics LLC||United States|
|4P Therapeutics LLC||United States|
|60° Pharmaceuticals, LLC||United States|
|7 Oaks Pharmaceutical Corp.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|NYC2012, Inc.||United States|
|Rush University||United States|
|The Advertising Council, Inc.||United States|
Sponsored Financial Commentaries
To contact InCarda Therapeutics, Inc., please visit incardatherapeutics.com. Company data is provided by Capital IQ. Please use this form to report any data issues.